The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Ricolinostat (ACY-1215) induced inhibition of aggresome formation accelerates carfilzomib-induced multiple myeloma cell death.

Mishima Y, Santo L, Eda H, Cirstea D, Nemani N, Yee AJ, O'Donnell E, Selig MK, Quayle SN, Arastu-Kapur S, Kirk C, Boise LH, Jones SS, Raje N. READ MORE

Posted: March 18, 2015

Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.

Berdeja JG, Hart LL, Mace JR, Arrowsmith ER, Essell JH, Owera RS, Hainsworth JD, Flinn IW. READ MORE

Posted: March 18, 2015

A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.

Hansson M, Gimsing P, Badros AZ, Martinsson Niskanen T, Nahi H, Offner F, Salomo M, Sonesson E, Mau-Sorensen M, Stenberg Y, Sundberg A, Teige I, van Droogenbroeck J, Wichert S, Zangari M, Frendeus B, Korsgren M, Poelman M, Tricot G. READ MORE

Posted: March 18, 2015

Page 70 of 87« First...102030...6869707172...80...Last »